Our treatment system consists of a unique combination of laser equipment and the IDOSE® software. The treatment system delivers laser light to the tumour using optical fibers. The treatment plan, including the optical fiber positions, is calculated by our patented dose planning platform IDOSE® using a 3D model of the treatment volume. The software calculates and controls the light dose continuously throughout the treatment. The same fibers are used for light delivery and measurements of optical parameters in the tissue for calculation of the light dose for each patient. Optimal light dose is crucial, as overexposure can result in damage to healthy tissue, while underexposure leads to incomplete treatment.
Before the system can be commercialised, the treatment with SpectraCure’s system must be proven to be effective, safe, and provide the intended clinical outcome. To demonstrate this, a clinical study is conducted.
“The SpectraCure IDOSE® system is an exciting new approach for estimating the extent of necrosis during PDT, based on real time measurements of light distribution and photobleaching in the area under treatment”
Stephen G Bown, MD (Cambridge), AM (Harvard), DSc (Hon Lucknow), FRCP Emeritus Prof of Laser Medicine & Surgery, Division of Surgery & Interventional Science
Photodynamic therapy (PDT) is a treatment that makes the tissue light-sensitive using a medication. Thereafter, the medication is activated by light of the optimal wavelength, and the resulting reaction kills the cancer cells. PDT is a well-established treatment method that is used for treatment of certain types of skin tumours.
Interstitial PDT is a further development of traditional PDT where the laser light is directly administrated into the tumour through optical fibers.
Our approach is unique as our proprietary system utilises the same optical fibers for both treatment and monitoring of the light dose. This allows the IDOSE® software to continuously calculate and regulate the laser light dose during the treatment, ensuring an optimal and individualised treatment with maximal effect.
SpectraCure’s treatment method, interstitial PDT, is performed with our treatment system consisting of:
Both the needles and optical fibers are disposable items supplied in a sterile treatment package.
SpectraCure’s PDT system with the IDOSE® software is a completely new medical device for treatment, planning, and laser light delivery. The treatment is local and adapted to each patient’s tumour.
A focal procedure, no open surgery.